Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2009 | 12-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||
| Net Income | -753 | -1,233 | -540 |
| Accounts receivable | -23 | N/A | -295 |
| Accounts payable and accrued liabilities | 94 | -277 | 52 |
| Other Working Capital | 551 | 98 | -118 |
| Other Operating Activity | 288 | 1,249 | 885 |
| Operating Cash Flow | $156 | $-163 | $-17 |
| Cash Flows From Investing Activities | |||
| Investing Cash Flow | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | N/A | 100 | N/A |
| Debt Repayment | -36 | N/A | N/A |
| Common Stock Issued | N/A | 50 | N/A |
| Other Financing Activity | 39 | -42 | 30 |
| Financing Cash Flow | $2 | $109 | $30 |
| Beginning Cash Position | 4 | 59 | 46 |
| End Cash Position | 163 | 4 | 59 |
| Net Cash Flow | $158 | $-55 | $14 |
| Free Cash Flow | |||
| Operating Cash Flow | 156 | -163 | -17 |
| Free Cash Flow | 156 | -163 | -17 |